spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Stratophase appoints Remy Martin as Business Development Manager

Stratophase

Stratophase has today announced the appointment of Remy Martin as Business Development Manager

Romsey, UK; 9 August 2017. Stratophase, the UK-based biopharmaceutical services and technology company, has today announced the appointment of Remy Martin as Business Development Manager.

Remy’s main responsibility will be to build and manage the company’s growing portfolio of Ranger® bioprocessing contract services. He will focus primarily on the European market and report to Stratophase CEO Simon Saxby.

Remy brings to Stratophase a wealth of experience and knowledge of upstream process development, process control and sensor technologies.

He joins the company from the University of Bristol, where he was employed as a Post-Doctoral Research Associate. Prior to that, Remy worked as a Bioreactor Specialist at Applikon Biotechnology UK, providing bespoke bioreactor control solutions.

Remy has a PhD in Biochemistry from the University of Bristol and an MBiol in Molecular & Cellular Biology from the University of Bath.

Commenting on Remy Martin’s appointment, CEO Simon Saxby said: “Remy’s enthusiasm for, and experience in, bioreactor control fit perfectly with the on-going development of Ranger© adaptive control contract services and their take-up by the global biopharma industry”.
phone +44 (0)1794 511226
email enquiries@stratophase.com
web https://www.stratophase.com
email Unit 10a, The Quadrangle, Premier Way , Romsey, Hampshire, SO51 9DL
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Synpromics announces a research collaboration with GE Healthcare to extend the toolbox for production of biologics

Edinburgh, UK, 4th January 2017 – Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform.
More info >>


White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

Industry Events

PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography

8-11 July 2018, Hyatt Regency in the Baltimore Inner Harbor, MD, USA

The PREP series of symposia is the most recognized international conference devoted to advances in separation technologies in the field of preparative and process chromatography. Join us for a dynamic and innovative program where experts from around the world will address the latest developments and hottest topics in preparative and process chromatography.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement